Articles Tagged With:
-
Surviving Spouse Awarded $1.1 Million for Patient’s Delayed Cancer Diagnosis
Although the parties disputed several essential facts in this case, one important, incontrovertible fact was the patient missed several follow-up appointments, failed to schedule tests recommended by the care providers, and thus contributed to her injuries. Physicians and care providers only have so much ability to compel patients to seek treatment.
-
Healthcare Personnel Hospitalizations and COVID-19 — with Possible Implications for Vaccine Prioritization
During the period of study, 5.9% of individuals hospitalized for COVID-19-related reasons were healthcare providers (HCP), with approximately one-third involving HCP who were not expected to have direct patient contact in the course of their work.
-
Online Ratings Pose Risk of Defamation, May Need Response
The risk of defamation increases with the proliferation of online rating services in the medical industry, experts say.
-
What to Do When Malpractice Allegations Become Defamation
Medical malpractice litigation can get ugly, with passionate plaintiffs and indignant clinicians or hospital administrators firing off heated accusations and insults. But where is the line where a malpractice allegation becomes defamation? What can be done when that happens?
-
Summary of HHS Guidance on Provider Relief Fund Compliance
The reporting requirements for the Provider Relief Fund should not be a surprise to healthcare organizations. “Free” money usually comes with a lot of strings attached.
-
Recommended Elements of a Compliance Program
Provider Relief Fund compliance will require an extensive and far-reaching program, experts note.
-
Provider Relief Funds Require Strict Compliance Program
Risk managers and compliance officers should act now to ensure compliance programs are consistent with the latest guidelines from the Department of Health and Human Services.
-
Norepinephrine Infusion Through Peripheral Intravenous Lines: Is it Safe?
In a large perioperative patient population, norepinephrine infusion through peripheral intravenous lines did not result in any significant adverse events. However, the specific patient population, limited duration of infusion, and hospital setting may limit the generalizability of these findings.
-
Do We Really Know the Optimal Oxygen Target in Patients with ARDS?
In the LOCO2 study, a conservative oxygen strategy with SpO2 goals of 88% to 92% was not shown to improve mortality over a liberal oxygen strategy as hypothesized, but rather was found to have a worrisome signal of increased mortality and increased mesenteric ischemia.
-
Management of Pulmonary-Renal Syndrome
The role of the intensivist in the management of pulmonary-renal syndrome includes appropriate respiratory support and recognition and management of concurrent infection, hypovolemia, acute anemia, and coagulopathy.